VEGFA and diabetes mellitus: In fact, more than half of patients who receive intravitreal injections for DME spend up to 20 h over a 6-month period with health care professionals for the management of diabetes and associated complications.16 Kiss et al17 have recently shown a linear correlation between the number of anti-VEGF injections and efficacy outcomes.